13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$560.18B
−0.8% on the quarter before
Positions
1,874
133 new · 146 sold out
Top 10
23.7%
of the value
Est. gain
+$7.49B
on stocks held all quarter
Est. return
+1.5%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 35% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$9.29BAdded · 1.8% → 3.9%+44,108,358 shares
- Broadcom~$1.59BAdded · 0.7% → 1.1%+988,184 shares
- SPDR S&P 500 ETF Tr~$1.52BAdded · 0.0% → 0.3%+2,789,442 shares
- T-Mobile Us Inc~$1.48BAdded · 0.2% → 0.5%+8,396,400 shares
- Nxp Semiconductors N V~$1.13BAdded · 0.4% → 0.7%+4,215,188 shares
- Mcdonalds Corp~$1.02BAdded · 0.5% → 0.7%+4,021,043 shares
- Tesla~$852.6MAdded · 0.0% → 0.2%+4,308,673 shares
- Bank America Corp~$820.3MAdded · 0.1% → 0.3%+20,626,628 shares
- Unitedhealth Group Inc~$815.0MAdded · 2.1% → 2.4%+1,600,285 shares
- Netflix~$813.7MAdded · 0.4% → 0.6%+1,205,623 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$3.16BCut · 1.5% → 1.0%−6,259,030 shares
- Alphabet~$2.92BCut · 2.0% → 1.9%−16,046,370 shares
- Amazon~$2.22BCut · 2.6% → 2.5%−11,481,910 shares
- Microsoft~$2.14BCut · 4.4% → 4.3%−4,782,702 shares
- Merck & Co Inc~$1.72BCut · 2.0% → 1.6%−13,866,280 shares
- Progressive Corp~$1.31BCut · 0.6% → 0.4%−6,323,381 shares
- Colgate Palmolive Co~$1.09BCut · 0.4% → 0.3%−11,242,976 shares
- Becton Dickinson & Co~$850.9MCut · 0.2% → 0.0%−3,641,008 shares
- Shockwave Med Inc~$850.2MSold out · 0.2% → 0.0%−2,610,975 shares
- Intel~$826.3MCut · 0.3% → 0.1%−26,679,539 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −8.1% · price +6.2% | 4.3% | $24.14B | +$1.42B | ||||||||
| AppleCOM · shares +74% · price +22.8% | 3.9% | $21.89B | +$2.34B | ||||||||
| NvidiaCOM · shares +1.4% · price +50.4% | 3.1% | $17.17B | +$5.68B | ||||||||
| AmazonCOM · shares −14% · price +7.1% | 2.5% | $13.74B | +$914.9M | ||||||||
| Unitedhealth Group IncCOM · shares +6.6% · price +2.9% | 2.4% | $13.18B | +$353.6M | ||||||||
| AlphabetCAP STK CL A · shares −22% · price +20.7% | 1.9% | $10.40B | +$1.78B | ||||||||
| Eli LillyCOM · shares −2.2% · price +16.4% | 1.7% | $9.76B | +$1.37B | ||||||||
| Merck & Co IncCOM · shares −16% · price −6.2% | 1.6% | $8.97B | −$590.7M | ||||||||
| Jpmorgan Chase & Co.COM · shares −7.9% · price +1.0% | 1.3% | $7.26B | +$70.4M | ||||||||
| Danaher CorporationCOM · shares −8.4% · price +0.1% | 1.1% | $6.12B | +$3.2M | ||||||||
| BroadcomCOM · shares +35% · price +21.1% | 1.1% | $6.06B | +$780.4M | ||||||||
| MetaCL A · shares −35% · price +3.8% | 1.0% | $5.81B | +$214.6M | ||||||||
| Procter And Gamble CoCOM · shares −1.1% · price +1.6% | 0.97% | $5.44B | +$88.1M | ||||||||
| Tjx Cos Inc NewCOM · shares −10% · price +8.6% | 0.87% | $4.90B | +$386.1M | ||||||||
| Texas InstrumentsCOM · shares +0.3% · price +11.7% | 0.86% | $4.83B | +$503.2M | ||||||||
| Pfizer IncCOM · shares −6.4% · price +0.8% | 0.83% | $4.65B | +$38.3M | ||||||||
| Visa Inc.COM CL A · shares +0.02% · price −6.0% | 0.82% | $4.58B | −$289.6M | ||||||||
| American Express CoCOM · shares −13% · price +1.7% | 0.79% | $4.42B | +$73.8M | ||||||||
| AlphabetCAP STK CL C · shares −0.6% · price +20.5% | 0.79% | $4.41B | +$748.6M | ||||||||
| Wells Fargo Co NewCOM · shares +19% · price +2.5% | 0.76% | $4.27B | +$86.1M | ||||||||
| MastercardCL A · shares −12% · price −8.4% | 0.74% | $4.13B | −$378.1M | ||||||||
| General Dynamics CorpCOM · shares −2.4% · price +2.7% | 0.73% | $4.09B | +$107.8M | ||||||||
| S&P Global IncCOM · shares +22% · price +4.8% | 0.68% | $3.82B | +$144.0M | ||||||||
| Stryker CorporationCOM · shares +3.7% · price −4.9% | 0.68% | $3.82B | −$190.9M | ||||||||
| Mcdonalds CorpCOM · shares +37% · price −9.6% | 0.68% | $3.81B | −$296.4M | ||||||||
| Total · 1,874 positions | 100% | $560.18B | +$7.49B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 1,640 stocks held throughout, up $7.49B (+1.5%).
- Nvidia11:1 split+$5.68B+50%
- Apple+$2.34B+23%
- Alphabet+$1.78B+21%
- Microsoft+$1.42B+6%
- Eli Lilly+$1.37B+16%
- Mastercard−$378.1M−8%
- Home Depot Inc−$389.9M−10%
- Salesforce−$393.9M−15%
- Accenture Plc Ireland−$429.4M−12%
- Merck & Co Inc−$590.7M−6%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |